JP2014520155A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520155A5 JP2014520155A5 JP2014517144A JP2014517144A JP2014520155A5 JP 2014520155 A5 JP2014520155 A5 JP 2014520155A5 JP 2014517144 A JP2014517144 A JP 2014517144A JP 2014517144 A JP2014517144 A JP 2014517144A JP 2014520155 A5 JP2014520155 A5 JP 2014520155A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- compound
- kupperman
- evaluation
- difficult
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 2
- 108010026552 Proteome Proteins 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- MBOMYENWWXQSNW-AWEZNQCLSA-N ixazomib citrate Chemical compound N([C@@H](CC(C)C)B1OC(CC(O)=O)(CC(O)=O)C(=O)O1)C(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl MBOMYENWWXQSNW-AWEZNQCLSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161499962P | 2011-06-22 | 2011-06-22 | |
| US61/499,962 | 2011-06-22 | ||
| PCT/US2012/043485 WO2012177835A1 (en) | 2011-06-22 | 2012-06-21 | Proteasome inhibitors and processes for their preparation, purification and use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520155A JP2014520155A (ja) | 2014-08-21 |
| JP2014520155A5 true JP2014520155A5 (enExample) | 2015-08-06 |
| JP5944986B2 JP5944986B2 (ja) | 2016-07-05 |
Family
ID=46395746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517144A Expired - Fee Related JP5944986B2 (ja) | 2011-06-22 | 2012-06-21 | プロテアソーム阻害剤、ならびにそれらの調製、精製、および使用のためのプロセス |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140121182A1 (enExample) |
| EP (1) | EP2723751A1 (enExample) |
| JP (1) | JP5944986B2 (enExample) |
| CA (1) | CA2833775A1 (enExample) |
| MX (1) | MX2013015308A (enExample) |
| WO (1) | WO2012177835A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016531886A (ja) * | 2013-10-03 | 2016-10-13 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 全身性エリテマトーデス及び／または狼瘡腎炎の予防または治療のための方法 |
| US10415964B2 (en) * | 2014-05-30 | 2019-09-17 | General Electric Company | Methods for producing passive strain indicator on turbine components |
| US9546928B2 (en) | 2014-05-30 | 2017-01-17 | General Electric Company | Methods for producing strain sensors on turbine components |
| MA41505A (fr) * | 2015-02-11 | 2017-12-19 | Millennium Pharm Inc | Nouvelle forme cristalline d'un inhibiteur de protéasome |
| CZ2015233A3 (cs) | 2015-04-03 | 2016-10-12 | Zentiva, K.S. | Způsob přípravy Ixazomib citrátu |
| CZ2015253A3 (cs) | 2015-04-15 | 2016-10-26 | Zentiva, K.S. | Nové formy Ixazomib citrátu |
| WO2016205790A2 (en) * | 2015-06-19 | 2016-12-22 | Hanlin Scientific, Inc. | Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis |
| CN106608883A (zh) * | 2015-10-21 | 2017-05-03 | 北京大学 | 蛋白酶体抑制剂mln9708的合成方法 |
| CN106986884A (zh) * | 2016-01-20 | 2017-07-28 | 成都贝斯凯瑞生物科技有限公司 | 一种高效的高纯度含硼化合物制备方法 |
| CN105732683B (zh) * | 2016-03-25 | 2018-10-16 | 南京林业大学 | 一类羧酸与α氨基酸组成的二肽硼酸及其酯类化合物、制备方法及其用途 |
| CZ2016204A3 (cs) | 2016-04-08 | 2017-11-01 | Zentiva, K.S. | Formulace Ixazomib citrátu formy 3 |
| WO2017198194A1 (zh) * | 2016-05-19 | 2017-11-23 | 成都奥璟生物科技有限公司 | 一种硼酸和硼酸酯类化合物及其应用 |
| TW201831191A (zh) * | 2017-01-23 | 2018-09-01 | 大陸商成都奥璟生物科技有限公司 | 一種新的硼酸衍生物及其藥物組合物 |
| CN109305980B (zh) * | 2017-07-28 | 2022-10-11 | 成都奥璟生物科技有限公司 | 一种硼酸酯化合物、其合成方法及其用途 |
| MX2021001089A (es) * | 2018-08-02 | 2021-05-12 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | Borato de derivado de azetidina. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| SI1756121T1 (sl) | 2004-03-30 | 2012-03-30 | Millennium Pharm Inc | Sinteza estra borove kisline in kislinske spojine |
| US7442830B1 (en) | 2007-08-06 | 2008-10-28 | Millenium Pharmaceuticals, Inc. | Proteasome inhibitors |
| EP2527347A1 (en) * | 2007-08-06 | 2012-11-28 | Millennium Pharmaceuticals, Inc. | Proteasome inhibitors |
| AU2009260778B2 (en) | 2008-06-17 | 2014-08-28 | Takeda Pharmaceutical Company Limited | Boronate ester compounds and pharmaceutical compositions thereof |
| EP2238973A1 (en) * | 2009-04-07 | 2010-10-13 | Cephalon France | Lyophilized preparations of proteasome inhibitors |
-
2012
- 2012-06-21 US US14/127,511 patent/US20140121182A1/en not_active Abandoned
- 2012-06-21 WO PCT/US2012/043485 patent/WO2012177835A1/en not_active Ceased
- 2012-06-21 JP JP2014517144A patent/JP5944986B2/ja not_active Expired - Fee Related
- 2012-06-21 EP EP12730349.3A patent/EP2723751A1/en not_active Withdrawn
- 2012-06-21 MX MX2013015308A patent/MX2013015308A/es unknown
- 2012-06-21 CA CA2833775A patent/CA2833775A1/en not_active Abandoned